Publication | Closed Access

Phase I clinical trial of irinotecan (CPT-11), 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, and cisplatin in combination with fixed dose of vindesine in advanced non-small cell lung cancer

OncologyMedicineFixed DoseBronchial NeoplasmPharmacotherapyAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologyLung CancerCancer Research